Medicine
Venlafaxine 100 mg tablet
Venlafaxine 100 mg tablet is a generic prescription medicine for oral use, made by 17 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Venlafaxine
- Brand
- Sold under the generic name
- Strength
- 100 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 100 tablets, 1000 tablets and 47 more
- Manufacturers
- Zydus LifesciencesIndiaAlembic PharmaceuticalsIndiaAurobindo PharmaIndiaDr. Reddy's LaboratoriesIndiaAvet PharmaceuticalsIndiaCadila PharmaceuticalsIndiaSun Pharmaceutical IndustriesIndiaRising Pharma HoldingsBluePoint LaboratoriesBryant Ranch Prepack17 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F) in a dry place.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06AX16 Venlafaxine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 August 2006
- Identifiers
- RxCUI 313580, 313582, 313584 +2DailyMed set ID 806b3e38-3b2a-4aaa-973c-e2d921bb353e, 80ac757d-c629-4579-8afd-cae0ee9cd614, db5f1693-ca64-7a97-e053-2995a90acbff +16NDC 70518-1976, 23155-250, 51655-717 +16Application ANDA090555, ANDA078554, ANDA078932 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 17 labelers. The register lists 50 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle | 46708-434-30 | Alembic PharmaceuticalsIndia | 1 October 2015 |
| 100 tablet in 1 bottle | 46708-434-31 | Alembic PharmaceuticalsIndia | 1 October 2015 |
| 1000 tablet in 1 bottle | 46708-434-91 | Alembic PharmaceuticalsIndia | 1 October 2015 |
| 30 tablet in 1 bottle | 62332-012-30 | Alembic PharmaceuticalsIndia | 1 October 2015 |
| 100 tablet in 1 bottle | 62332-012-31 | Alembic PharmaceuticalsIndia | 1 October 2015 |
| 1000 tablet in 1 bottle | 62332-012-91 | Alembic PharmaceuticalsIndia | 1 October 2015 |
| 100 tablet in 1 bottle | 65841-675-01 | Zydus LifesciencesIndia | 13 June 2008 |
| 500 tablet in 1 bottle | 65841-675-05 | Zydus LifesciencesIndia | 13 June 2008 |
| 30 tablet in 1 bottle | 65841-675-06 | Zydus LifesciencesIndia | 13 June 2008 |
| 1000 tablet in 1 bottle | 65841-675-10 | Zydus LifesciencesIndia | 13 June 2008 |
| 60 tablet in 1 bottle | 65841-675-14 | Zydus LifesciencesIndia | 13 June 2008 |
| 90 tablet in 1 bottle | 65841-675-16 | Zydus LifesciencesIndia | 13 June 2008 |
| 100 tablet in 1 bottle | 68382-101-01 | Zydus LifesciencesIndia | 13 June 2008 |
| 500 tablet in 1 bottle | 68382-101-05 | Zydus LifesciencesIndia | 13 June 2008 |
| 30 tablet in 1 bottle | 68382-101-06 | Zydus LifesciencesIndia | 13 June 2008 |
| 1000 tablet in 1 bottle | 68382-101-10 | Zydus LifesciencesIndia | 13 June 2008 |
| 60 tablet in 1 bottle | 68382-101-14 | Zydus LifesciencesIndia | 13 June 2008 |
| 90 tablet in 1 bottle | 68382-101-16 | Zydus LifesciencesIndia | 13 June 2008 |
| 100 tablet in 1 bottle | 65862-408-01 | Aurobindo PharmaIndia | 7 April 2010 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 65862-408-10 | Aurobindo PharmaIndia | 7 April 2010 |
| 20 tablet in 1 bottle | 65862-408-20 | Aurobindo PharmaIndia | 7 April 2010 |
| 6000 tablet in 1 bottle | 65862-408-66 | Aurobindo PharmaIndia | 7 April 2010 |
| 90 tablet in 1 bottle | 65862-408-90 | Aurobindo PharmaIndia | 7 April 2010 |
| 1000 tablet in 1 bottle | 65862-408-99 | Aurobindo PharmaIndia | 7 April 2010 |
| 100 tablet in 1 bottle | 23155-250-01 | Avet PharmaceuticalsIndia | 19 July 2021 |
| 90 tablet in 1 bottle | 23155-250-09 | Avet PharmaceuticalsIndia | 19 July 2021 |
| 100 tablet in 1 bottle | 71209-029-05 | Cadila PharmaceuticalsIndia | 3 December 2018 |
| 100 tablet in 1 bottle | 55111-549-01 | Dr. Reddy's LaboratoriesIndia | 16 June 2008 |
| 500 tablet in 1 bottle | 55111-549-05 | Dr. Reddy's LaboratoriesIndia | 16 June 2008 |
| 30 tablet in 1 bottle | 55111-549-30 | Dr. Reddy's LaboratoriesIndia | 16 June 2008 |
| 60 tablet in 1 bottle | 55111-549-60 | Dr. Reddy's LaboratoriesIndia | 16 June 2008 |
| 1 blister pack in 1 carton / 10 tablet in 1 blister pack | 55111-549-79 | Dr. Reddy's LaboratoriesIndia | 16 June 2008 |
| 90 tablet in 1 bottle | 55111-549-90 | Dr. Reddy's LaboratoriesIndia | 16 June 2008 |
| 100 tablet in 1 bottle | 57664-396-88 | Sun Pharmaceutical IndustriesIndia | 13 June 2008 |
| 100 tablet in 1 bottle | 57237-176-01 | Rising Pharma Holdings | 7 April 2010 |
| 90 tablet in 1 bottle | 57237-176-90 | Rising Pharma Holdings | 7 April 2010 |
| 100 tablet in 1 bottle | 0093-9163-01 | Teva Pharmaceuticals | 4 August 2006 |
| 100 tablet in 1 bottle, plastic | 50771-005-02 | Yaopharma | 6 September 2016 |
| 100 tablet in 1 bottle | 68001-156-00 | BluePoint Laboratories | 25 November 2013 |
| 30 tablet in 1 bottle | 71335-2709-1 | Bryant Ranch Prepack | 26 September 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 December 1993 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Venlafaxine
Clinical summary
Venlafaxine is a serotonin and norepinephrine reuptake inhibitor indicated in adults for the treatment of major Depressive Disorder (MDD), among other approved uses. It is available as extended-release capsules, tablets and extended-release tablets for oral use. MedsAcross supplies Venlafaxine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about VenlafaxineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Effexor XR prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
Need Venlafaxine 100 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.